Table 5.
Differences in secondary outcomes between the two treatment groups
| Adjusted | ||||||||
|---|---|---|---|---|---|---|---|---|
| LAT | AMIS | LAT | AMIS | Effect | p | Effect | p | |
| n | n | Mean | Mean | Delta | Delta | |||
| Postoperative delirium | 89 | 77 | 0.94 | 0.87 | −0.07 | 0.667 | −0.12 | 0.468 |
| LOS | 96 | 78 | 11.39 | 10.97 | −0.41 | 0.630 | −0.70 | 0.393 |
| Operative time | 97 | 82 | 100.1 | 96.3 | −3.8 | 0.419 | −5.3 | 0.253 |
| Erythrocyte concentrates within 72 h | 97 | 82 | 0.73 | 0.50 | −0.23 | 0.174 | −0.31 | 0.078 |
| % | % | RR | RR | |||||
| Implant related infections | 96 | 79 | 5.2 | 8.9 | 1.70 | 0.347 | 1.81 | 0.281 |
| SAE during follow up | 90 | 73 | 30.0 | 26.0 | 0.87 | 0.577 | 0.90 | 0.682 |
| Return to no WA at 3 months | 45 | 23 | 28.9 | 26.1 | 0.90 | 0.809 | 0.80 | 0.578 |
| Return to no WA at 12 months | 34 | 17 | 61.8 | 64.7 | 1.05 | 0.836 | 0.94 | 0.829 |
| %dead | %dead | HR | HR | |||||
| 1 year mortality | 99 | 82 | 20.2 | 28.0 | 1.46 | 0.205 | 1.64 | 0.149 |
The results are more favorable in the LAT arm for the avoidance of implant related infections and the one-year mortality. There is also an advantage for return to no walking aids at three months. The AMIS arm, on the other hand was more favorable for all the other aspects analyzed. However, none of the differences reached statistical significance. Adjustment was performed for pfFIM and age
WA Walking aid, SAE serious adverse event or surgery related complication